ReNeuron Group (ReNeuron Group) Price-to-Operating-Cash-Flow : (As of Apr. 30, 2024)

View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Price-to-Operating-Cash-Flow?

As of today (2024-04-30), ReNeuron Group's share price is $0.05055. ReNeuron Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.11. Hence, ReNeuron Group's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for ReNeuron Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

RNUGF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.83
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

ReNeuron Group's Cash Flow from Operations per share for the six months ended in Sep. 2023 was $-0.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.11.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 33.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 25.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.10% per year.

During the past 13 years, ReNeuron Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 46.30% per year. The lowest was -20.90% per year. And the median was 19.10% per year.

ReNeuron Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ReNeuron Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Price-to-Operating-Cash-Flow Chart

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ReNeuron Group's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, ReNeuron Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ReNeuron Group's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's Price-to-Operating-Cash-Flow falls into.

ReNeuron Group Price-to-Operating-Cash-Flow Calculation

ReNeuron Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.05055	/	-0.112
	=

ReNeuron Group's Share Price of today is $0.05055.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ReNeuron Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.11.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

ReNeuron Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group (ReNeuron Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

RENE.GB:UK RENE:UK RQE1:Germany

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.